ArticleTrials2024

Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.

Taylan Gurgenci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.